The industry, the pharmaceutical environment. The compliance rate in 2004 was something like 95%. It has now gradually drifted down, and you're going to see it in our annual report, to about 89%. You say it's only 5%, but that 5% may represent many companies, may represent many drugs, each one of which deserves its own investigation.
Now, the drugs in Canada—and you're going to hate to hear this—are the second or third most expensive in the world. Our industry is not suffering excessively. The highest prices in the world are in the United States, which has very few price controls. Recently we were second highest in the world. Now I'm told that we are probably the third highest in the world. We used to be right in the middle. We used to be at the median. We have seven comparator countries. I think you've heard about how this works. Now we are actually slightly higher than the median. We are slightly higher, so we are spending more on our drugs in Canada.